RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.10, Iss.2, 2013-02, pp. : 273-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug delivery systems for the topical treatment of cutaneous leishmaniasis

By Carneiro Guilherme Aguiar Marta Gontijo Fernandes Ana Paula Ferreira Lucas Antônio Miranda

Expert Opinion on Drug Delivery, Vol. 9, Iss. 9, 2012-09 ,pp. : 1083-1097

Informa Healthcare

Access to resources Recommend Favorite

Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?

By Lugaresi Alessandra

Expert Opinion on Drug Delivery, Vol. 6, Iss. 9, 2009-09 ,pp. : 995-1002

Informa Healthcare

Access to resources Recommend Favorite

Provider Feedback Improves Adherence with AHCPR Smoking Cessation Guideline

By Andrews J.O. Tingen M.S. Waller J.L. Harper R.J.

Preventive Medicine, Vol. 33, Iss. 5, 2001-11 ,pp. : 415-421

Academic Press

Access to resources Recommend Favorite

Improving adherence to injectable disease-modifying drugs in multiple sclerosis

By Bayas Antonios

Expert Opinion on Drug Delivery, Vol. 10, Iss. 3, 2013-03 ,pp. : 285-287

Informa Healthcare

Access to resources Recommend Favorite

Expert Opinion on Drug Delivery, Vol. 9, Iss. 11, 2012-11 ,pp. : 1-1

Informa Healthcare

Access to resources Recommend Favorite